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Clinical Characteristics and Survival of Patients with
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Dan J. Raz, MD,* David V. Glidden, PhD,† Anobel Y. Odisho, BA,‡ and David M. Jablons, MD*
Background: There is little information on the clinical characteris-
tics and outcomes of patients with surgically resected, incidentally
detected lung cancers. Our hypothesis was that among patients with
surgically resected non-small cell lung cancer (NSCLC), inciden-
tally detected cancers were common, were less likely to require
pneumonectomy, and were associated with better stage-adjusted
survival.
Methods: Two hundred seventy-four patients with NSCLC who
underwent surgical resection between 1999 and 2004 were studied.
The clinical characteristics of patients with incidentally detected and
symptomatic NSCLC were compared. A proportional hazards model
was used to compare the stage-adjusted mortality rate of patients
with incidentally detected and symptomatic NSCLC.
Results: One hundred patients (36%) had incidentally detected
NSCLC. Patients with incidentally detected NSCLC had smaller and
earlier-stage cancers, were less likely to undergo pneumonectomy
(3% versus 13%, p  0.005), and were more likely to have
bronchioloalveolar carcinoma (15% versus 5%, p 0.003). Patients
with incidentally detected cancers had a stage-adjusted hazards ratio
(HR) of mortality of 0.9 compared with symptomatic patients
(0.6–1.4, p  0.64). Patients with cancers detected incidentally on
computed tomography (CT) had a stage-adjusted HR of 0.5 (0.2–
1.5, p  0.15).
Conclusions: Early-stage NSCLC is commonly detected inciden-
tally. Patients with incidentally detected lung cancers are more likely
to have bronchioloalveolar carcinoma histology, less likely to un-
dergo pneumonectomy, and overall have similar stage-adjusted
survival compared with symptomatic patients. Patients with cancers
detected incidentally by CT scan may have better stage-adjusted
survival, but our study was not sufficiently powered to detect this
effect.
Key Words: Lung cancer, Early detection, Surgery, Early stage,
Screening, Bronchioloalveolar carcinoma.
(J Thorac Oncol. 2007;2: 125–130)
Lung cancer kills more people than breast, colon, andprostate cancers combined.1 Long-term survival of breast,
colon, and prostate cancers has substantially improved during
the past 30 years, partly because of early detection by screen-
ing. In contrast, lung cancer survival has not significantly
improved during the same time period. Screening for lung
cancer is not currently recommended for current or former
smokers, on the basis of the findings of three large chest x-ray
and sputum cytology screening trials.2–4 Although several
computed tomography (CT) screening trials are currently
underway, conclusive results are not expected for several
more years.5 Despite the absence of endorsed screening
protocols, incidentally detected lung cancers may comprise a
large proportion of lung cancer patients treated by thoracic
surgeons.
Yet, there is little information on the clinical charac-
teristics and outcomes of patients with incidentally detected
early-stage lung cancer. Kanashiki and colleagues6 report that
15% of all lung cancers and 50% of stage I lung cancers
diagnosed at their institution were incidentally detected. In
that series, which included patients diagnosed up to 30 years
ago, only 30% of incidentally detected lung cancers were
surgically resected. Conclusions about the characteristics and
outcomes of this relatively small proportion of patients with
incidentally detected cancers who underwent resection may
not be generalizable to patients with incidentally detected
early-stage disease. More information is needed on the pro-
portion and characteristics of patients with early-stage non-
small cell lung cancer (NSCLC) whose disease was detected
incidentally. As the volume of radiologic imaging increases
with improving technology and accessibility, a larger number
of patients with lung cancer may be detected incidentally.
The clinical and histologic differences among patients with
incidental compared with symptomatic NSCLC may shed
light on several intriguing questions. It is unclear whether
patients with incidentally detected lung cancer have better
stage-adjusted long-term survival compared with symptom-
atic patients. Moreover, it is unknown whether there are
differences in clinical characteristics and histology among
patients with incidentally detected lung cancers compared
with symptomatic lung cancers. Patients with incidentally
detected NSCLC may, on average, have more indolent tu-
mors than patients with symptomatic tumors. Slow-growing
tumors such as bronchioloalveolar carcinoma (BAC) may be
more common among incidentally detected cancers and may
be associated with improved stage-adjusted survival. A larger
number of women and never-smokers might suggest a dif-
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ferent population of lung cancers that are detected inciden-
tally but that may not have gone on to cause symptomatic
disease. Finally, patients with incidentally detected lung can-
cer might be less likely to undergo pneumonectomy than
patients with symptomatic lung cancer because they might be
less likely to have central tumors.
We set out to determine whether there were differences
in the clinical and histologic characteristics of patients with
completely resected incidental and symptomatic lung cancer.
Moreover, we compared the stage-adjusted survival of pa-
tients with incidentally detected lung cancer and patients with
symptomatic lung cancer.
METHODS
Between 1999 and 2004, 291 consecutive patients un-
derwent surgical resection of lung cancer with negative his-
tologic margins and mediastinal nodal sampling at our insti-
tution. Preoperatively, patients were asked to complete a
questionnaire on symptoms, tobacco exposure history, and
medical history. Fifteen patients with incomplete information
on symptoms leading to diagnosis and two patients who died
within 30 days of operation were excluded. Stage was deter-
mined using the most recent American Joint Committee
Classification (AJCC) of lung cancer tumor, node, metastasis
staging classification. Vital status and date of death were
determined using the Social Security Death Index (http://
ssdi.genealogy.rootsweb.com).
Patients who had no symptoms attributable to lung
cancer at the time of imaging, or patients with transient
symptoms thought to be unrelated to lung cancer, were
classified as having incidentally detected cancer. We re-
viewed the charts of patients who were classified in our
clinical database as having incidentally detected lung cancers
to validate the classification and to determine the indications
for imaging. Agreement between initial classification as
incidental and classification by study investigators was
determined using an unweighted  statistic. Study inves-
tigators were not blinded to the initial classification of
symptoms by clinicians who originally entered data into
the clinical database.
Tumor size was measured at the time of surgical resec-
tion. Among patients treated with neoadjuvant chemotherapy,
tumor size was estimated as the larger of the size of the tumor
on the CT scan preceding chemotherapy treatment or the size
at the time of resection.
This research study involved analysis of existing data
from the University of California–San Francisco Thoracic
Oncology clinical database, with no subject intervention. This
study was approved by the University of California–San
Francisco institutional review board (approval number H8714-
28880-01).
Statistical Analysis
Statistical analysis was performed using STATA re-
lease 9.1 (College Park, TX). Clinical and histopathologic
features of patients detected incidentally and symptomatically
were compared. Student’s t test was used to compare the
means of two continuous variables, and Pearson’s chi-square
test or Fisher’s exact test were used to compare categorical
variables. The Mann–Whitney rank-sum test was used to
compare the means of continuous variables not normally
distributed. Unadjusted survival was compared between
groups using the log-rank test.
A proportional hazards model was used to determine
the hazard ratio (HR) of death for incidental detection of lung
cancer, adjusting for stage of disease. Time to failure was
defined as time from treatment (either lung resection or
initiation of neoadjuvant chemotherapy). AJCC stage was
adjusted for as a categorical variable (stage I, II, IIIa, and
IIIb/IV). Incidental detection was included as a variable in the
model. A sensitivity analysis was performed, excluding pa-
tients with chest-related symptoms and patients diagnosed
with another cancer within 5 years of lung cancer diagnosis.
The proportional hazards model was repeated, adjust-
ing for tumor size, hilar nodal involvement, mediastinal nodal
involvement, chest wall invasion, mediastinal invasion, and
satellite nodules, rather than the AJCC composite stage. This
model allows for more accurate stage adjustment and testing
of interactions. The analysis was again repeated, using time
from the start of symptoms or time from the imaging study
leading to the incidental detection of lung cancer as the time
function. This analysis was performed because patients may
have been followed for months or years before resection of
incidentally detected masses, and time from detection may
better reflect survival time. Likelihood ratio testing was used
to calculate p values. The proportional hazards model as-
sumption was tested by inspection of log-minus-log survival
plots. Interactions were tested by including cross-product
terms in the proportional hazards model.
RESULTS
Of 274 patients in this study, 100 patients (36%) had
incidentally detected lung cancers. Eighty-one (30%) patients
were diagnosed incidentally on chest x-ray, 17 patients (6%)
on CT scan, and two patients (1%) on positron emission
tomography (PET) scan. Primary symptoms of all patients in
this study are listed in Table 1. Agreement between the initial
TABLE 1. Primary Symptoms of 274 Patients Undergoing
Lung Cancer Resection
n %
Incidental on CXR 81 29.6
Incidental on CT 17 6.2





Chest wall pain 15 5.5
Shoulder or back pain 14 5.1
Weight loss 11 4.0
Wheeze 3 1.1
Other symptoms 18 6.6
CXR, chest x-ray; CT, computed tomography; PET, positron emission tomography.
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classification of incidental detection and the classification by
the study authors was excellent (  0.92).
Indications for imaging leading to the incidental detec-
tion of lung cancer are listed in Table 2. Imaging was
obtained for screening purposes in 25 patients (25%). Our
institution is not a participating site in any lung cancer
screening trial. Most of screening studies were ordered by
physicians as an annual chest x-ray, although some patients
requested screening x-rays for lung cancer because of a
family history of lung cancer or a long smoking history.
Other patients had a chest x-ray taken for tuberculosis screen-
ing for immigration purposes or for nursing home residency.
Twelve patients (12%) had transient chest-related symptoms
that were considered unlikely to be related to the lung cancer
detected. Examples of these include chest wall pain located
on the opposite side of the thorax as the detected lung cancer,
pneumonia in a different pulmonary lobe than the detected
lung cancer, and transient chest pain related to myocardial
infarction.
We compared the clinical and histopathologic features
of patients detected incidentally and symptomatically, as
shown in Table 3. Patients with incidentally detected lung
cancer were somewhat younger that patients with symptom-
atic lung cancers (66 versus 70 years, p  0.0005) and were
more likely to have earlier-stage disease, smaller cancers (2.5
versus 3.5 cm, p  0.0008), and BAC (15% versus 5%, p 
0.003). Sixty-five percent of patients with BAC were detected
incidentally, compared with 34% of all other histologic sub-
types (p  0.003). Forty-seven percent of patients with
incidentally detected lung cancer on CT scan had pure BAC
or adenocarcinoma with BAC features (p  0.005). Patients
with symptomatic cancers were more likely to have large cell
carcinoma (8% versus 1%, p  0.021). Patients with inci-
dental lung cancer were less likely than symptomatic patients
to undergo pneumonectomy (3% versus 13%, p  0.005). A
similar number of patients underwent sublobar resection of
lung cancer. We reserve sublobar resections for patients with
severe COPD, multifocal lung cancer, elderly patients with
multiple comorbidities who are unable to tolerate lobectomy,
and select patients with subcentimeter peripheral lung cancers.
In the proportional hazards model (Table 4), incidental
detection of lung cancer had an HR of death of 0.90 (95% CI
[0.58–1.40], p  0.64) relative to patients with symptomatic
lung cancers. After excluding patients with chest-related
symptoms or cancer within 5 years, the HR of death for
incidental detection was 1.00 (95% CI [0.61–1.64], p 
0.99). After adjusting for individual variables comprising the
composite stage, including tumor size, the HR for incidental
detection was 1.13 (0.71–1.81, p  0.60). Using time from
the start of symptoms or imaging as the time function, the
model gave similar HRs for all variables (data not shown).
Kaplan–Meier curves for long-term survival of incidentally
detected compared with symptomatic lung cancers are shown
in Figure 1A.
The stage-adjusted HR of death for lung cancers de-
tected incidentally on CT scan was 0.47 (0.15–1.49, p 
0.15) using AJCC stage adjustment. The HR was similar
when stage was adjusted for using individual variables.
TABLE 2. Indications for Imaging Among 100 Patients with




Staging/surveillance for cancer 16
Evaluation of chest symptoms thought to be unrelated 12
Evaluation of nonchest, nonabdominal symptoms 9
Evaluation of abdominal pain 7
Trauma 3
Evaluation of ILD 3
Coronary screening CT scan 2
Patient not aware of reason for CXR 7
CXR, chest x-ray; CT, computed tomography; ILD, interstitial lung disease.





(n  174) p
Age (mean  SD) 66  11 70  9 0.0005
Male (n, %) 42 (42%) 83 (48%) 0.36
Smoking history
Current smoker 32 (32%) 52 (30%) 0.50
Past smoker 52 (52%) 84 (48%)
Never-smoker 16 (16%) 38 (22%)
Race/ethnicity
Caucasian 80 (80%) 139 (80%) 0.45
African American 6 (6%) 3 (2%)
Asian American 9 (9%) 24 (14%)
Hispanic 2 (2%) 5 (3%)
Other 3 (3%) 3 (2%)
Stage of disease
1 72 (72%) 75 (43%) 0.0001
2 6 (6%) 37 (21%)
3a 13 (13%) 25 (14%)
3b 9 (9%) 29 (17%)
4 0 7 (4%)
Tumor size (median, IQR) 2.5 (2.1–3.8) 3.5 (2.5–5) 0.0008
Histology
Adenocarcinoma 37 (37%) 63 (36%) 0.97
Mixed BAC* 18 (18%) 19 (11%) 0.099
BAC 15 (15%) 8 (5%) 0.003
Squamous cell 20 (20%) 43 (25%) 0.37
Large cell 1 (1%) 13 (8%) 0.021
Undifferentiated NSCLC 9 (9%) 28 (16%) 0.098
Operation performed
Sublobar resection 16 (16%) 16 (9%) 0.091
Lobectomy 77 (77%) 121 (70%) 0.18
Bilobectomy 4 (4%) 14 (8%) 0.22
Pneumonectomy 3 (3%) 23 (13%) 0.005
IQR, interquartile range; BAC, bronchioloalveolar carcinoma. NSCLC, non-small
cell lung cancer. Mixed BAC is synonymous with adenocarcinoma with bronchioloal-
veolar features.
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Kaplan–Meier curves for long-term survival of lung cancers
detected incidentally on CT scan compared with symptomatic
lung cancers are shown in Figure 1B.
CONCLUSIONS
More than one third of patients who underwent com-
plete surgical resection of lung cancer at our institution had
incidentally detected cancers. Half of all patients with stage I
NSCLC had incidentally detected lung cancers. The most
common indication for imaging among patients with inciden-
tally detected lung cancer was a screening exam, even though
lung cancer screening with chest radiography is not recom-
mended by the American Cancer Society or any other major
medical organization. The demographics and smoking history
of patients with incidentally detected cancers were similar to
those of patients with symptomatic lung cancer, except that
patients with incidentally detected lung cancers were some-
what younger. Not surprisingly, patients with incidentally
detected lung cancer had smaller cancers and earlier-stage
disease.
Patients with completely resected incidental lung can-
cer had similar long-term survival rates as patients with
symptomatic lung cancer, after adjusting for stage. Patients
with incidentally detected lung cancer who had no chest-
related complaints or other primary cancer within 5 years of
diagnosis of lung cancer had an HR of 1.00 of death. Patients
with incidentally detected lung cancers on CT scan had an
HR of 0.47 of death (0.15–1.49, p  0.15), although the
confidence interval included the possibility that incidentally
detected lung cancers had similar survival compared with
symptomatic lung cancers. Lower stage-adjusted mortality
rates among patients with incidentally detected lung cancers
may be attributable to the presence of clinically insignificant
lung cancers, length–time bias, or inadequate adjustment for
disease stage. Length–time bias occurs when slow-growing
lung cancers are more frequently detected on screening than
biologically aggressive cancers, leading to overestimation of
the effect of screening on mortality reduction.
Kanashiki and colleagues6 report improved survival
among patients detected incidentally, although a relatively
small number of patients underwent surgical resection, and it
is unclear how the authors adjusted survival for stage. Be-
cause a majority of patients in that series had advanced lung
cancer, it is possible that asymptomatic patients had less
advanced disease than symptomatic lung cancer, which was
not adequately adjusted for in the analysis.
Although demographics and survival seemed to be
similar between incidental and symptomatic lung cancers in
FIGURE 1. A, Kaplan–Meier survival curves of incidentally detected compared with symptomatic lung cancers. B, Kaplan–
Meier survival curves of cancers detected incidentally on computed tomography scan, compared with all other lung cancers.
TABLE 4. Proportional Hazards Models of Lung Cancer
Mortality, Adjusting for Stage
HR 95% CI p
A. Model excluding incidental
cancers with chest-related
symptoms or history of other
cancer within 5 years of diagnosis
Incidentally detected 1.00 0.61–1.64 0.99
Stage II 0.77 0.36–1.66 0.51
Stage IIIa 2.23 1.29–3.86 0.004
Stage IIIb/IV 2.66 1.58–4.46 0.001
B. Model including all
incidental lung cancers
Incidentally detected 0.90 0.58–1.40 0.64
Stage II 0.77 0.36–1.66 0.51
Stage IIIa 2.23 1.29–3.87 0.004
Stage IIIb/IV 2.67 1.59–4.48 0.001
C. Incidental lung cancers
detected by CT
Incidental by CT 0.47 0.15–1.49 0.15
Stage II 0.77 0.36–1.63 0.49
Stage IIIa 2.31 1.33–3.99 0.003
Stage IIIb/IV 2.70 1.63–4.47 0.001
HR, hazards ratio; CI, confidence interval; CT, computed tomography.
HRs for all stages are referenced to stage I. HRs for incidental detection are
referenced to symptomatic cancers.
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our study, patients with incidentally detected lung cancer
were three times as likely to have BAC histology. Sixty-five
percent of patients with BAC were detected incidentally,
compared with 34% of all other histologic subtypes (p 
0.003). Moreover, 47% of patients with incidentally detected
lung cancer on CT scan had BAC histology (pure BAC or
adenocarcinoma with BAC features) (p  0.005). BAC
histology is commonly found in small lung cancers and may
represent a precursor lesion to lung adenocarcinoma.7 It is not
surprising that small lesions detected incidentally will often
have BAC histology. A recent review of the histopathology
of surgically resected lung cancers detected on CT screening
as part of the Early Lung Cancer Action Program reported
that more than two thirds of cancers had BAC histology
(either BAC or mixed adenocarcinoma with BAC features).8
Yet, the natural history of small tumors with BAC histology
is unknown. Small BACs may evolve into adenocarcinomas
if left untreated, but some of these small BACs may remain
slow growing and noninvasive and may not be of any clinical
significance. Several series from Japan have reported that
complete resection of solitary pure BAC smaller than 2 cm
are associated with 5-year survival rates of 90% to 100%,
underscoring the indolent biology of these tumors relative to
less differentiated lung cancers.9–13 Yet, BAC is uncom-
monly reported in autopsy series.14,15 It is possible that small,
subtle BAC lesions were missed at autopsy or that BAC was
incorrectly classified as adenocarcinoma or carcinoma in situ.
Although the goal of lung cancer screening is to im-
prove lung cancer survival, early detection of lung cancer
may have an additional benefit of reducing the need for
pneumonectomy in patients with central tumors. In this study,
patients detected incidentally were significantly less likely to
undergo pneumonectomy than symptomatic patients (3%
versus 13%, p  0.005). This finding is likely explained by
the detection of smaller tumors and fewer centrally located
cancers in the incidentally detected group. This observation
suggests that early detection of lung cancer may reduce the
frequency of pneumonectomy, which carries greater periop-
erative morbidity and mortality than lobectomy and may not
be tolerated by patients with compromised pulmonary func-
tion. It is unclear to what extent the cost of early detection of
lung cancers is substantiated by the benefit of a reduction in
the frequency of pneumonectomy.
A limitation of this study is the potential bias intro-
duced by the classification of a cancer as incidentally detected
when transient chest-related symptoms were present. To
overcome this limitation, we reviewed the indications for
imaging for patients classified as having an incidentally
detected cancer. Agreement with initial classification of in-
cidental detection was excellent (  0.92). We identified
patients with chest-related symptoms thought to be unrelated
to the lung cancers, and we excluded these patients in a
sensitivity analysis. We also identified patients with lung
cancers detected for surveillance or staging of another pri-
mary cancer. We performed a sensitivity analysis excluding
these patients because inclusion of these patients might
falsely increase the mortality rate among patients with inci-
dentally detected cancers. There was no meaningful change
in the HR for incidental detection of lung cancer after
excluding these groups of patients. Another possible limita-
tion of this study was that survival time was measured as time
from treatment. Patients with incidentally detected lung can-
cers may have been observed with serial imaging for months
or years before treatment, potentially underestimating sur-
vival time by using time from treatment as the time function.
To explore this potential bias, we estimated time from begin-
ning of symptoms or the time from the imaging study that led
to the incidental detection of lung cancer, and we repeated the
proportional hazards model. The models using time from
symptoms or time from treatment as the time function had
similar coefficients. This suggests that, on average, time to
treatment is similar when a patient has symptoms and when
a patient has incidentally detected cancer.
Another limitation of this study is that this is a single-
institution experience with a relatively small sample size. We
may have been able to draw stronger conclusions with a
larger number of patients from a multiple institutions. Be-
cause our institution is a large referral center, it was not
possible to determine the number of people who may have
been diagnosed with lung cancer incidentally but who were
not referred for surgery. Despite this limitation, this is the
largest series of surgically resected, incidentally detected lung
cancers in the literature to our knowledge. In comparison, only
52 patients with incidentally detected lung cancer underwent
surgical resection in the series published by Kanashiki and
colleagues.6
In conclusion, many patients who undergo surgical
resection of lung cancer have incidentally detected cancers,
especially among patients with stage I NSCLC. Although
screening for lung cancer is not yet supported by existing
data, a large proportion of patients with early-stage lung
cancers are detected incidentally. We expect that the number
of incidentally detected lung cancers will grow as the volume
of CT scanning for coronary screening, pulmonary embolism,
aortic disease, and abdominal pain increases. Our results
suggest that among surgically resected lung cancers, there is
no overall difference in stage-adjusted survival when com-
paring incidental with symptomatic lung cancers, but there
may be lower stage-adjusted mortality among patients with
lung cancers detected incidentally on CT. Nevertheless, our
confidence intervals were too wide to make these conclusions
with certainty. Whether a clinically meaningful number of
patients detected by screening will be harmed as a result of
treatment of clinically indolent lung cancers will only be
answered by the results of lung cancer screening trials cur-
rently underway.
REFERENCES
1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer
J Clin 2006;56:106–130.
2. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE,
Muhm JR. Lung cancer screening: the Mayo program. J Occup Med
1986;28:746–750.
3. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection:
results of the initial (prevalence) radiologic and cytologic screening in
the Johns Hopkins study. Am Rev Respir Dis 1984;130:549–554.
4. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA,
Martini N. Screening for early lung cancer. Results of the Memorial
Sloan-Kettering study in New York. Chest 1984;86:44–53.
Journal of Thoracic Oncology • Volume 2, Number 2, February 2007 Surgically Resected, Incidentally Detected Lung Cancer
Copyright © 2007 by the International Association for the Study of Lung Cancer 129
5. Bepler G, Goodridge Carney D, Djulbegovic B, Clark RA, Tockman M.
A systematic review and lessons learned from early lung cancer detec-
tion trials using low-dose computed tomography of the chest. Cancer
Control 2003;10:306–314.
6. Kanashiki M, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K. Outcome of
patients with lung cancer detected incidentally. Oncol Rep 2004;12:945–948.
7. Raz DJ, He B, Rosell R, Jablons DM. Current concepts in bronchioloal-
veolar carcinoma biology. Clin Cancer Res 2006;12:3698–3704.
8. Flieder DB, Vazquez M, Carter D, et al. Pathologic findings of lung tumors
diagnosed on baseline CT screening. Am J Surg Pathol 2006;30:606–613.
9. Watanabe S, Watanabe T, Arai K, Kasai T, Haratake J, Urayama H.
Results of wedge resection for focal bronchioloalveolar carcinoma
showing pure ground-glass attenuation on computed tomography. Ann
Thorac Surg 2002;73:1071–1075.
10. Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma
of the lung 3 centimeters or less in diameter: a prognostic assessment.
Ann Thorac Surg 2004;78:1728–1733.
11. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of
the lung. Histologic characteristics and prognosis. Cancer 1995;75:
2844–2852.
12. Higashiyama M, Kodama K, Yokouchi H, et al. Prognostic value of
bronchiolo-alveolar carcinoma component of small lung adenocarci-
noma. Ann Thorac Surg 1999;68:2069–2073.
13. Asamura H, Suzuki K, Watanabe S, Matsuno Y, Maeshima A, Tsuchiya
R. A clinicopathological study of resected subcentimeter lung cancers: a
favorable prognosis for ground glass opacity lesions. Ann Thorac Surg
2003;76:1016–1022.
14. McFarlane MJ, Feinstein AR, Wells CK. Clinical features of lung
cancers discovered as a postmortem “surprise”. Chest 1986;90:520–
523.
15. Manser RL, Dodd M, Byrnes G, Irving LB, Campbell DA. Incidental
lung cancers identified at coronial autopsy: implications for over-
diagnosis of lung cancer by screening. Respir Med 2005;99:501–
507.
Raz et al. Journal of Thoracic Oncology • Volume 2, Number 2, February 2007
Copyright © 2007 by the International Association for the Study of Lung Cancer130
